Showing 1631-1640 of 18593 results for "".
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
https://reachmd.com/programs/neurofrontiers/examining-inebilizumab-in-generalized-myasthenia-gravis-insights-from-mint/32859/Even though the available therapeutic options for generalized myasthenia gravis (gMG) have improved outcomes, challenges like incomplete responses, treatment fatigue, and side-effect burdens remain. That's why the MINT trial, published in The New England Journal of Medicine in June 2025, explored thImproving Conduit and Neobladder Efficiency: Surgical and Post-Operative Strategies
https://reachmd.com/programs/clinicians-roundtable/Improving-conduit-and-neobladder-efficiency-surgical-and-post-operative-strategies/33038/Optimizing urinary diversion and continence techniques is essential for improving patient outcomes and quality of life following surgery. Join Dr. Mutahar Ahmed as he provides expert guidance on improving success in conduits and neobladders in the operating room and beyond. Dr. Ahmed is the DirectorUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
https://reachmd.com/programs/neurofrontiers/understanding-schizophrenia-the-role-of-neurotransmission-and-inflammation/36637/Our understanding of schizophrenia’s pathophysiology continues to evolve, highlighting the complex interplay between neurotransmitter dysregulation, inflammation, and progressive gray matter loss. Learn more with Dr. Jeffrey Lieberman, the Constance and Stephen Lieber Professor of Psychiatry at ColuPrecision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
https://reachmd.com/clinical-practice/cardiology/precision-medicine-in-obstructive-hcm-care-the-promise-of-cardiac-myosin-inhibitors/48692/Explore the promise of cardiac myosin inhibitors and how they are marking a paradigm shift in obstructive HCM Care.Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
https://reachmd.com/programs/medical-industry-feature/immune-imprinting-and-vaccines-rethinking-the-first-exposure-to-influenza/26669/Discover the potential role of immune imprinting in shaping how we approach influenza vaccination.Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
https://reachmd.com/programs/project-oncology/dato-dxd-intracranial-efficacy-nsclc/36609/A recent post-hoc analysis of the TROPION-Lung01 trial—which was presented at the 2025 World Conference on Lung Cancer—sheds light on the intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients with advanced non-small cell lung cancer (NSCLC) and baseline brain metastases. The findingAssessing Milk and Egg Ladders for Pediatric IgE-Mediated Allergies
https://reachmd.com/programs/frontlines-food-allergies/assessing-milk-and-egg-ladders-for-pediatric-ige-mediated-allergies/30037/Find out how milk and egg ladders can help gradually introduce allergenic protein at home to children with IgE-mediated allergies.Breaking the Cycle: Understanding and Managing Inflammatory Memory in Psoriasis
https://reachmd.com/programs/clinicians-roundtable/breaking-the-cycle-understanding-and-managing-inflammatory-memory-in-psoriasis/32446/Inflammatory memory may influence symptom recurrence in psoriasis patients. Learn about how it works and strategies for promoting sustained remission.Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
https://reachmd.com/programs/medical-industry-feature/igan-pathogenesis-april-4-hit-process-patient-case-study/29535/In IgA nephropathy (IgAN), patients have a high burden of kidney disease at diagnosis, often presenting with chronic kidney disease stage ≥3.1-3 Early recognition is critical for management. That’s why Dr. Abby Yancey and Dr. Kartik Kalra explore IgAN’s underlying pathogenesis, heterogeneity in initArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
https://reachmd.com/programs/clinicians-roundtable/artificial-intelligence-in-dermatology-exploring-new-diagnostic-strategies/32382/Explore how artificial intelligence can support dermatologists by aiding in skin lesion classification and detecting malignancies.